Crossmark

Possible adverse events of imidazole antifungal drugs during treatment of vulvovaginal candidiasis: analysis of the FDA Adverse Event Reporting System

Crossref DOI link: https://doi.org/10.1038/s41598-024-63315-1

Published Online: 2024-06-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhou, Tianyu

Chen, Chongze

Chen, Xiaowei

Wang, Bin

Sun, Feng

Li, Wanfang

Liu, Dong

Jin, Hongtao
Funding

Funding for this research was provided by:

Clinical Toxicology of Chinese Society of Toxicology (CST2021CT101)
License Information

Text and Data Mining valid from 2024-06-24

Version of Record valid from 2024-06-24
More Information

Article History

Received: 26 December 2023

Accepted: 27 May 2024

First Online: 24 June 2024

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below